Quality by Design in the Vaccines world

In February I published an article on the topic of Quality by Design as it applies to the Vaccines World. This was based on a presentation at an IBC conference on vaccine development. As you might imagine, QbD has been slow in development of biologics but even slower in Vaccines. Check out the article on the IBC website

Posted in Clinical Manufacturing, GMP, Process Validation, Quality by Design, Risk Management| Tags: Services|